about
Immunoliposomal systems targeting primary effusion lymphoma: in vitro study.B cells and herpesviruses: a model of lymphoproliferation.Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patientsDifferences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicilyβ-HHVs and HHV-8 in Lymphoproliferative Disorders.Mucorales-Specific T Cells in Patients with Hematologic Malignancies.Changes in T-cell responses against human herpesvirus-8 correlate with the disease course of iatrogenic Kaposi's sarcoma in a patient with undifferentiated arthritis.Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis.Frequent detection of human herpesvirus-6 sequences by polymerase chain reaction in paraffin-embedded lymph nodes from patients with angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity.Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation.BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes.How I treat HHV8/KSHV-related diseases in posttransplant patients.Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma.Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation.The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi.Immunologic evidence of a strong association between non-Hodgkin lymphoma and simian virus 40.Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: A 3-year prospective study.Human herpesvirus-6: a survey of presence and distribution of genomic sequences in normal brain and neuroglial tumors.Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma.Is it now the time to update treatment protocols for lymphomas with new anti-virus systems?Indirect antitumor effects of mammalian target of rapamycin inhibitors against Kaposi sarcoma in transplant patients.Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center stuAcute appendicitis in adult neutropenic patients with hematologic malignancies.Fatal hemophagocytic syndrome related to active human herpesvirus-8/Kaposi sarcoma-associated herpesvirus infection in human immunodeficiency virus-negative, non-transplant patients without related malignancies.Suppressive effect of human herpesvirus-8/Kaposi sarcoma-associated herpesvirus on in vitro colony formation of hematopoietic progenitor cells.Human herpesvirus 8 (HHV8) infection and related diseases in Italian transplant cohorts.Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6.Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia.Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia.Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma.Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL.Successful Treatment of Kaposi Sarcoma-Associated Herpesvirus Inflammatory Cytokine Syndrome After Kidney-Liver Transplant: Correlations With the Human Herpesvirus 8 miRNome and Specific T Cell Response.Human herpesvirus 6 infection in normal human brain tissue.NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis.HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role?Prevalence of human herpesvirus-6 chromosomal integration (CIHHV-6) in Italian solid organ and allogeneic stem cell transplant patients.
P50
Q33704280-9A7E440F-9C95-4272-93B9-1F50BAD2E950Q34717891-F99435B3-40EC-408A-B9AF-8904A4ED9317Q34984670-9E406EA6-D0FF-4369-B9E2-AD32D1B8DA7FQ35249061-0FEB5110-8273-4B6F-9718-890E7AC19F13Q35560251-21DDEFC9-D48C-4156-8996-2D9D2B7AEE87Q35922089-2D9A563F-46EB-472D-B59A-08CC7FB2A1D6Q37221105-BA9A86BE-C6A8-412F-AE00-CEB65F2B792AQ38030534-C9C1D42F-0935-491D-B731-82C77689B706Q38484955-EE99BC92-B59A-4376-8202-270BD8C4B72AQ38815306-C9DE661D-746A-44C3-94AF-33FF3140463EQ38930292-8242FBAD-57B8-47B8-BE71-E2CC70117489Q39122060-A87EA28E-4BA2-4A73-90E5-376166C58EEFQ39549868-8796D75B-8802-4FCE-8056-0E92A43B17B5Q39554617-2DBEB4B7-25A4-486C-8E36-8997B4543C72Q39684574-BF2747BD-869C-4A7A-B9F8-0547ACE924E6Q40278222-4BF5226E-1D20-44FB-AFBC-A7D4AE67BE73Q40856883-9AB7E690-9E57-4F63-B53B-4D2D3B7B748CQ41069112-2E625BC5-9BA5-4F59-AE94-305547B2A5E7Q42253765-5A56FF12-66E8-4449-9075-F210B772404AQ42513645-549767A0-BE51-4C7D-9809-1AC6515D1F3FQ42910824-B0C00397-8E25-46D6-B6FF-5B4E4A1DA097Q42986624-F101EB2A-3196-4AD0-99F5-D1A2D23E8B07Q43288494-A7B044A3-AE37-43DC-A3F7-6DBB488459DFQ43645374-E05D4C34-FACC-49C8-B01B-BBAA821679A1Q43653484-EFCD1401-2D9D-4361-B408-95E2908B5EA4Q44457701-7380861C-5A47-4E26-AC9F-623DC3628B5CQ44597707-1D90355F-DFDF-4973-BA96-1FE96D74F584Q44786116-F0023E2C-E7B7-45A7-891D-62F86E09BE28Q45240547-4116B5C1-B219-42EC-948E-DB2BAE1CF2E8Q45334689-DCCA6E55-806A-4126-ABED-64D7AA2DBC46Q45755081-DD34730F-E710-4875-9114-BF23042BFA9EQ45977241-5D9473B1-EDF5-4665-B92E-51DC37F69E11Q46367987-BB55BA5B-6D9D-4058-BA8D-55BD1F64BEE5Q46446491-BDF11B7D-F4EE-428D-9172-EC0F0CE56DF0Q47783260-04D375BD-ED4A-4A75-A340-08BD0CDD12BCQ48145531-97A4610C-B901-4EB2-97D2-FB4B5DBD49CFQ53221793-A756243E-8EFD-4C0C-BE34-D4406E438D0AQ54362642-60598A89-EE67-4801-829C-602E5540E2F8Q54442287-47F7211E-2FBC-46B1-B2E4-63754469E402Q54478013-4BADA17E-D59C-4FAE-87AE-06636A075448
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Patrizia Barozzi
@ast
Patrizia Barozzi
@en
Patrizia Barozzi
@es
Patrizia Barozzi
@nl
type
label
Patrizia Barozzi
@ast
Patrizia Barozzi
@en
Patrizia Barozzi
@es
Patrizia Barozzi
@nl
prefLabel
Patrizia Barozzi
@ast
Patrizia Barozzi
@en
Patrizia Barozzi
@es
Patrizia Barozzi
@nl
P106
P1153
7003373700
P21
P31
P496
0000-0002-8936-1114